Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials von Hanania, Nicola A, Dr, Korenblat, Phillip, Prof, Chapman, Kenneth R, Prof, Bateman, Eric D, Prof, Kopecky, Petr, MD, Paggiaro, Pierluigi, Prof, Yokoyama, Akihito, Prof, Olsson, Julie, MD, Gray, Sarah, PhD, Holweg, Cecile T J, PhD, Eisner, Mark, MD, Asare, Charles, MD, Fischer, Saloumeh K, PhD, Peng, Kun, PhD, Putnam, Wendy S, PhD, Matthews, John G, MB BS

Volltext

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies von Hanania, Nicola A, Noonan, Michael, Corren, Jonathan, Korenblat, Phillip, Zheng, Yanan, Fischer, Saloumeh K, Cheu, Melissa, Putnam, Wendy S, Murray, Elaine, Scheerens, Heleen, Holweg, Cecile TJ, Maciuca, Romeo, Gray, Sarah, Doyle, Ramona, McClintock, Dana, Olsson, Julie, Matthews, John G, Yen, Karl

Volltext

Point-of-care and utility in clinical trials: making quicker decisions to transform patient care and drug development von Fischer, Saloumeh K.

Volltext

Evaluation of low volume sampling devices for a pharmacodynamic biomarker analysis: Challenges and solutions von Yang, Xiaoyun, Logis, Evelin, Williams, Kathi, Sheng, X. Rebecca, Fischer, Saloumeh K.

Volltext

Overcoming Soluble Target Interference in Measurement of Total Bispecific Therapeutic Antibody Concentrations von Shim, Jeongsup, Chen, Jessica, Carrasco-Triguero, Montserrat, Fischer, Saloumeh K.

Volltext

Assessment of low volume sampling technologies: utility in nonclinical and clinical studies von Williams, Kathi J., Lutman, Jeff, McCaughey, Cynthia, Fischer, Saloumeh K.

Volltext

Validation of low-volume sampling devices for pharmacokinetic analysis: technical and logistical challenges and solutions von Yang, Xiaoyun, Williams, Kathi, Elliott, Rebecca, Hokom, Martha, Allen, Janis, Fischer, Saloumeh K

Volltext

Expanding assay range to accommodate a monoclonal antibody therapeutic quantification in blood and cerebrospinal fluid von Foley, Alejandro R, Sperinde, Gizette, Fischer, Saloumeh K

Volltext

A generic anti-drug antibody assay for monoclonal antibody therapeutics with broad dynamic range eliminates the need for titer evaluation in preclinical studies von Li, Hao, Foley, Alejandro R., Shim, Jeongsup, Siradze, Ketevan, Webb-Vargas, Yenny, Sperinde, Gizette, Fischer, Saloumeh K.

Volltext

Development of an IL-6 point-of-care assay: utility for real-time monitoring and management of cytokine release syndrome and sepsis von Fischer, Saloumeh K, Williams, Kathi, Wang, Ling, Capio, Emmanuel, Briman, Mikhail

Volltext

Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood von Hendricks, Robert, Baker, Dana, Brumm, Jochen, Davancaze, Teresa, Harp, Chris, Herman, Ann, von Büdingen, H-Christian, Townsend, Michael, Fischer, Saloumeh K

Volltext

Pre-analytical stability of ocrelizumab in serum after delayed centrifugation of whole blood von Shim, Jeongsup, Carrasco-Triguero, Montserrat, Fischer, Saloumeh K.

Volltext

Novel Selective Quantification of Zinpentraxin Alfa Biotherapeutic in the Presence of Endogenous Isomer in Plasma Samples of Idiopathic Pulmonary Fibrosis Patients Using Immunoaffi... von Li, Maoyin, Arjomandi, Audrey, Sun, Xiaowei, Lu, Erhu, Tyagi, Tulika, Lin, WeiYu, Fischer, Saloumeh K., Kaur, Surinder, Xu, Keyang

Volltext

Successful Development of Nonclinical Anti-Drug Antibody Assays to Support Zinpentraxin Alfa Reproductive Toxicology Studies von Arjomandi, Audrey, Siradze, Ketevan, Cheu, Melissa, Davancaze, Teresa, Yadav, Rajbharan, Rao, Gautham K., Wong, Lisa, Fischer, Saloumeh K.

Volltext

Factors contributing to the nonlinear pharmacokinetics of astegolimab: a close examination of potential causes von Sperinde, Gizette, Dolton, Michael, Zhang, Wenhui, Mathews, Joel, Putnam, Wendy, Fischer, Saloumeh K

Volltext

Emerging Technologies to Increase Ligand Binding Assay Sensitivity von Fischer, Saloumeh K., Joyce, Alison, Spengler, Mark, Yang, Tong-Yuan, Zhuang, Yao, Fjording, Marianne Scheel, Mikulskis, Alvydas

Volltext

Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics von Bumbaca Yadav, Daniela, Sharma, Vikas K., Boswell, Charles Andrew, Hotzel, Isidro, Tesar, Devin, Shang, Yonglei, Ying, Yong, Fischer, Saloumeh K., Grogan, Jane L., Chiang, Eugene Y., Urban, Konnie, Ulufatu, Sheila, Khawli, Leslie A., Prabhu, Saileta, Joseph, Sean, Kelley, Robert F.

Volltext

The Development and Characterization of a Highly Sensitive Mature TGFβ3 Assay to Evaluate Anti-TGFβ3 Target Engagement von Setiadi, A. Francesca, Sperinde, Gizette, Cheu, Melissa, Liang, Wei-Ching, Lin, WeiYu, Mahood, Connie, Fischer, Saloumeh K.

Volltext

Measurement of IL-17AA and IL-17FF as Pharmacodynamic Biomarkers to Demonstrate Target Engagement in the Phase I Study of MCAF5352A von Peng, Kun, Wang, Yehong, Siradze, Ketevan, Erickson, Rich, Fischer, Saloumeh K., Staton, Tracy L.

Volltext

Evaluation of two point of care technologies for measuring monoclonal antibody therapeutic-A concentrations in blood von Fischer, Saloumeh K., Williams, Kathi, Harmon, Ian, Bothwell, Bryan, Xu, Hua, Capio, Emmanuel, Briman, Mikhail

Volltext